Ziad Hussein
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Reappraising prediction of surgical complexity of non-functioning pituitary adenomas after transsphenoidal surgery: the modified TRANSSPHER grade.
Journal: Pituitary
Published: December 27, 2024
Conservatively managed non-functioning pituitary macroadenomas-cohort study from the UK Non-functioning Pituitary Adenoma Consortium.
Journal: European journal of endocrinology
Published: December 21, 2024
Population pharmacokinetics and exposure-response analyses of safety (ARIA-E and isolated ARIA-H) of lecanemab in subjects with early Alzheimer's disease.
Journal: CPT: pharmacometrics & systems pharmacology
Published: February 28, 2024
Machine Learning Analysis of Post-Operative Tumour Progression in Non-Functioning Pituitary Neuroendocrine Tumours: A Pilot Study.
Journal: Cancers
Published: January 29, 2024
Population pharmacokinetic-pharmacodynamic modeling of serum biomarkers as predictors of tumor dynamics following lenvatinib treatment in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC).
Journal: CPT: pharmacometrics & systems pharmacology
Published: November 28, 2023
Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium.
Journal: European journal of endocrinology
Published: April 12, 2023
Post-Operative Medium- and Long-Term Endocrine Outcomes in Patients with Non-Functioning Pituitary Adenomas-Machine Learning Analysis.
Journal: Cancers
Published: April 04, 2023
Non-functioning pituitary macroadenoma following surgery: long-term outcomes and development of an optimal follow-up strategy.
Journal: Frontiers in surgery
Published: December 21, 2022
A combined physiologically-based pharmacokinetic and quantitative systems pharmacology model for modeling amyloid aggregation in Alzheimer's disease.
Journal: CPT: pharmacometrics & systems pharmacology
Published: October 18, 2022
First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742, a Dual Antagonist of Toll-like Receptors 7 and 8, in Healthy Volunteers.
Journal: Clinical pharmacology in drug development
Published: August 09, 2022
Pituitary function at presentation and following therapy in patients with non-functional pituitary macroadenomas: a single centre retrospective cohort study.
Journal: Endocrine
Published: July 18, 2022
Exposure-Response Analyses of Polysomnography and Subjective Sleep Efficacy End Points From the Phase 3 Trials of Lemborexant, a Dual Orexin Receptor Antagonist for the Treatment of Insomnia.
Journal: Journal of clinical pharmacology
Published: June 07, 2022
Last Updated: 09/26/2026